Literature DB >> 18180805

Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men.

K Fujimoto1, M Tanaka, Y Hirao, Y Nagata, M Mori, N Miyanaga, H Akaza, W-J Kim.   

Abstract

Racial differences in the incidence of prostate cancer are manifest worldwide, possibly due to the different dietary habits. To elucidate the relationship between the recent trend of phytoestrogenic isoflavone intake and the increased incidence of prostate cancer in Japan, we conducted an age-stratified dietary survey of soybean foods in 102 Japanese healthy men (age range: 10-59 years) and measured the serum isoflavones and equol levels in them and 100 Korean healthy men. The intergroup comparison among the age-stratified groups showed significant differences in the daily intake of genistein and daidzein between the teenager group and the other groups of age >or=30 years (P<0.05). In the Japanese study, the proportion of equol producers in the teenager group was 10%, being significantly the lowest among the age-stratified groups. The proportions of equol producers in the age-stratified groups from 10 to 49 years were also significantly lower than those in the fifties. The equol non-producers consumed significantly less amounts of isoflavones than the equol producers. In the Korean study, the proportions of equol producers were 45% in the teenager and 40% in the twenties and thirties, being significantly lower than in the forties (80%) and fifties (65%). The decreased intake of isoflavones, low serum level of equol and low incidence of equol production in the young generation may become potential risk factors for prostate cancer not only in Japan but also in Korea in the near future. Elucidating the mechanism of equol production may be promising in developing strategies for chemoprevention against prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180805     DOI: 10.1038/sj.pcan.4501030

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  15 in total

1.  Cautions and research needs identified at the equol, soy, and menopause research leadership conference.

Authors:  Stephen Barnes; Helen Kim
Journal:  J Nutr       Date:  2010-05-26       Impact factor: 4.798

Review 2.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

Review 3.  Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome".

Authors:  Hideyuki Akaza
Journal:  Cancer Sci       Date:  2012-04-16       Impact factor: 6.716

Review 4.  Effect of Soy and Soy Isoflavones on Obesity-Related Anthropometric Measures: A Systematic Review and Meta-analysis of Randomized Controlled Clinical Trials.

Authors:  Masoumeh Akhlaghi; Morteza Zare; Fatemeh Nouripour
Journal:  Adv Nutr       Date:  2017-09-15       Impact factor: 8.701

Review 5.  Therapeutic perspectives of epigenetically active nutrients.

Authors:  M Remely; L Lovrecic; A L de la Garza; L Migliore; B Peterlin; F I Milagro; A J Martinez; A G Haslberger
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

6.  Plasma isoflavone concentration is associated with decreased risk of type 2 diabetes in Korean women but not men: results from the Korean Genome and Epidemiology Study.

Authors:  Kwang-Pil Ko; Cheong-Sik Kim; Younjhin Ahn; Seon-Joo Park; Yeon-Jeong Kim; Jae Kyung Park; Young-Khi Lim; Keun-Young Yoo; Sung Soo Kim
Journal:  Diabetologia       Date:  2014-12-23       Impact factor: 10.122

7.  Isoflavone supplements stimulated the production of serum equol and decreased the serum dihydrotestosterone levels in healthy male volunteers.

Authors:  M Tanaka; K Fujimoto; Y Chihara; K Torimoto; T Yoneda; N Tanaka; A Hirayama; N Miyanaga; H Akaza; Y Hirao
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-07-14       Impact factor: 5.554

8.  Levels of urinary isoflavones and lignan polyphenols in Japanese women.

Authors:  Wanyang Liu; Miyako Tanabe; Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2013-04-30       Impact factor: 3.674

9.  Plasma genistein and risk of prostate cancer in Chinese population.

Authors:  Yishuo Wu; Limin Zhang; Rong Na; Jianfeng Xu; Zuquan Xiong; Ning Zhang; Wanjun Dai; Haowen Jiang; Qiang Ding
Journal:  Int Urol Nephrol       Date:  2015-05-14       Impact factor: 2.370

10.  Chemoprevention of prostate cancer: soy isoflavones and curcumin.

Authors:  Shigeo Horie
Journal:  Korean J Urol       Date:  2012-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.